Neonatal Patent Ductus Arteriosus
Research activity includes clinical care for extremely low gestational age neonates with patent ductus arteriosus, with attention to duct-related outcomes and complications linked to early-life cardiovascular instability.
- Neonatal pharmacotherapy
- Ductal closure
- Bronchopulmonary dysplasia
- Premature infant care
The sponsor’s work in this area is centered on treatment strategies used in neonatal intensive care, especially approaches relevant to respiratory and cardiovascular morbidity in very premature infants.
Acute Venous Thromboembolism
Clinical research also addresses acute venous thromboembolism, focusing on anticoagulant treatment options and the balance between efficacy and bleeding risk in patients requiring therapy for venous clotting disorders.
- Direct oral anticoagulants
- Bleeding safety
- Venous clot management
- Thromboembolic disease
This area reflects interest in comparative treatment options for thrombosis and the clinical selection of anticoagulant agents in routine vascular medicine.
Addison’s Disease
Work in Addison’s disease focuses on adrenal insufficiency management, with particular attention to hydrocortisone replacement, symptom control, and patient-centered outcomes such as daily function and wellbeing.
- Glucocorticoid therapy
- Circadian rhythm
- Sleep quality
- Quality of life
Therapeutic interest extends to hormone replacement strategies that support more stable symptom control in chronic endocrine disease.
